MECLOMEN Drug Patent Profile
✉ Email this page to a colleague
When do Meclomen patents expire, and what generic alternatives are available?
Meclomen is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in MECLOMEN is meclofenamate sodium. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the meclofenamate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meclomen
A generic version of MECLOMEN was approved as meclofenamate sodium by MYLAN on September 3rd, 1986.
Summary for MECLOMEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,376 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MECLOMEN at DailyMed |
Recent Clinical Trials for MECLOMEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The University of Texas Health Science Center, Houston | Phase 2 |
US Patents and Regulatory Information for MECLOMEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | MECLOMEN | meclofenamate sodium | CAPSULE;ORAL | 018006-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Parke Davis | MECLOMEN | meclofenamate sodium | CAPSULE;ORAL | 018006-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
